Part, Chapter, Paragraph
1 I, 2. 6 | and EFTA countries.~ ~The indicator shows the percentage of
2 I, 2. 6 | secondary education. The indicator aims at measuring the share
3 I, 3. 1 | fertility rate (TFR = an indicator corresponding to the mean
4 II, 4.Acr | Global Activity Limitation Indicator~HLY~Healthy Life Years~LE~
5 II, 4. 1 | HLY), a health expectancy indicator among the Structural Indicators.
6 II, 4. 1 | the first EU Structural Indicator on health and in its 2005
7 II, 4. 1 | reporting one’s own health, this indicator is likely to be more appropriate
8 II, 4. 1 | the HLY as a Structural Indicator, using survey data coming
9 II, 4. 1 | prosperity. Thus, HLY as the indicator to monitor health within
10 II, 4. 3 | Global Activity Limitation Indicator (GALI): Sozial- und Präventivmedizin
11 II, 5. 2. 3 | most valid and reliable indicator. According to the MONICA
12 II, 5. 3.Acr | EUROCHIP~European Cancer Health Indicator Project~FACT~Fighting Against
13 II, 5. 3. 1 | population and is a useful indicator for planning and allocation
14 II, 5. 3. 3 | for men and women. This indicator is available for selected
15 II, 5. 4. 2 | OECD indicators~ ~ ~Areas~ ~Indicator Name~Processes of diabetes
16 II, 5. 4. 2 | over 20 countries~ ~Core indicator~ ~Countries with recent
17 II, 5. 4. 2 | Prevalence over 25 yrs, an EUCID indicator, is very similar to the
18 II, 5. 4. 2 | the percentage for this indicator varied from 2% (Turkey)
19 II, 5. 4. 2 | most fundamental outcome indicator of all, through which countries
20 II, 5. 4. 2 | of health policies. This indicator is defined as the annual
21 II, 5. 4. 2 | over 20 countries~Secondary indicator~ ~Countries with~recent
22 II, 5. 4. 2 | Level of HbA1c>7.0% is an indicator of poor management causing
23 II, 5. 4. 2 | of HbA1c above 7.0%. This indicator is also measured by OECD,
24 II, 5. 4. 2 | 5 mmol/l is an important indicator of lipidic control that
25 II, 5. 4. 2 | 6 mmol/l is an important indicator of lipidic control that
26 II, 5. 4. 2 | months is also taken as an indicator for lipids, measured by
27 II, 5. 4. 2 | 3 mmol/l is an important indicator of lipidic control that
28 II, 5. 4. 2 | The clinical management indicator is defined as the percentage
29 II, 5. 4. 2 | is an extremely difficult indicator to collect, unless there
30 II, 5. 4. 2 | complications. The process indicator is measured by the percentage
31 II, 5. 4. 2 | in last 12 months. This indicator is the only one reported
32 II, 5. 4. 2 | proliferative retinopathy.~Indicator on timely laser treatment
33 II, 5. 4. 3 | the percentage for this indicator varied from 2% (Turkey)
34 II, 5. 4. 3 | median of 79 (Denmark). The indicator decreases before the age
35 II, 5. 4. 3 | last 12 months. The EUCID indicator varies between countries
36 II, 5. 4. 3 | last 12 months. The EUCID indicator varies in 11 countries between
37 II, 5. 4. 3 | ranging between 1% and 14%.~Indicator on timely laser treatment
38 II, 5. 4. 3 | of retinopathy. For this indicator, data is even more scarce
39 II, 5. 4. 3 | major amputations. This indicator, measured by EUCID across
40 II, 5. 4. 3 | influence of age on the indicator: the older the individual,
41 II, 5. 4. 3 | median equal to 654.5. The indicator is age dependant with a
42 II, 5. 4. 6 | the “European Diabetes Indicator Project” (EUDIP) has provided
43 II, 5. 5. 3 | has been shown to be an indicator for a more severe disease
44 II, 5. 9. 5 | asthma related deaths as an indicator of the quality of ambulatory
45 II, 7. 3. 2 | the most frequently used indicator for injuries and has a high
46 II, 7. 4 | European Community Health Indicator system (ECHI) is a proposal
47 II, 7. 7 | discharge database (2008): Indicator 494 - Number of eligible
48 II, 8. 1. 2 | last 6 months or more. The indicator used is the percentage prevalence
49 II, 8. 2. 1 | participation and also as a key indicator of quality of life (AAMR,
50 II, 9 | mothers and children and is an indicator of effective antenatal preventive
51 II, 9. 1. 1 | rates between countries.~ ~ ~Indicator~Definition~Points to consider
52 II, 9. 1. 1 | charged with developing an indicator set for monitoring and describing
53 II, 9. 1. 1 | resulting EURO-PERISTAT indicator set reflects a solid base
54 II, 9. 1. 1 | breast-feeding at birth~F: Indicator of support to women~F: Indicator
55 II, 9. 1. 1 | Indicator of support to women~F: Indicator of maternal satisfaction~
56 II, 9. 1. 1 | Monitoring~CP is a recommended indicator by EURO-PERISTAT for long-term
57 II, 9. 1. 1 | al (2003): Selecting an indicator set for monitoring and evaluating
58 II, 9. 1. 2 | mothers and children and is an indicator of effective antenatal preventive
59 II, 9. 2. 2 | opportunity can be a prime indicator: across all Member States
60 II, 9. 3. 2 | Mortality~ ~The EURO-PERISTAT indicator list includes one core indicator
61 II, 9. 3. 2 | indicator list includes one core indicator for monitoring maternal
62 II, 9. 3. 2 | EURO-PERISTAT recommended indicator, but this indicator is still
63 II, 9. 3. 2 | recommended indicator, but this indicator is still being developed
64 II, 9. 3. 2 | feasibility and quality of an indicator based on a set of conditions
65 II, 9. 3. 2 | hospital discharge data. This indicator is determined by the number
66 II, 9. 3. 2 | 1a.~ ~The EURO-PERISTAT indicator set specified several key
67 II, 9. 3. 2 | was also targeted as an indicator for further development
68 II, 9. 3. 2 | al (2003): Selecting an indicator set for monitoring and evaluating
69 II, 9. 3. 3 | at a very young age is an indicator of a higher probability
70 III, 10. 2. 1 | whereby the education is an indicator of the socio-economic status.
71 III, 10. 2. 1 | Addiction~TDI~Treatment demand indicator~ ~ ~
72 III, 10. 2. 1 | and can thus be used as an indicator of problem drug use. The
73 III, 10. 2. 1 | use is also an important indicator to understand the characteristics
74 III, 10. 2. 1 | in the Treatment Demand Indicator (TDI) data set, while the
75 III, 10. 2. 1(17)| about ‘Treatment Demand Indicator’ please visit http ds~
76 III, 10. 2. 2 | incidence, which is a good indicator of the magnitude of the
77 III, 10. 2. 5 | European Community Health Indicator (ECHI) long list includes
78 III, 10. 2. 5 | long list includes the indicator “Pregnant women smoking”,
79 III, 10. 3. 1 | period of 8 hours. The noise indicator for the night time period,
80 III, 10. 3. 2 | decreasing. Breast milk is a good indicator of human exposure to persistent
81 III, 10. 3. 2 | is regularly used as an indicator of exposure. The bio-monitoring
82 III, 10. 4. 1 | respiratory symptoms. This indicator is also well correlated
83 III, 10. 4. 2 | Non dioxin-like PCBs~(‘indicator’ PCBs)~ ~Oils and fats of
84 III, 10. 4. 2 | standards for the seven~‘indicator’ PCBs; EU: risk~assessment
85 III, 10. 4. 5 | assessment of the core set indicator “Progress in management
86 III, 10. 4. 5 | assessment of the core set indicator “Progress in management
87 III, 10. 5. 1 | cities with data on this indicator).~ ~
88 III, 10. 5. 1 | city-level data is merely an indicator to monitor the general trends
89 III, 10. 5. 1 | development of an urban health indicator system as an essential part
90 III, 10. 6. 1 | 1.2.1 The Mental health indicator pilot study~This pilot study,
91 III, 10. 6. 1 | parents is considered to be an indicator of social support from parents
92 IV, 11. 1. 3 | concept might be used as an indicator for health system performance
93 IV, 11. 1. 3 | sought to develop a single indicator of performance. However,
94 IV, 11. 1. 3 | Furthermore, a composite indicator compounds the inaccuracy
95 IV, 11. 1. 4 | Although health status as an indicator of need is the most commonly
96 IV, 11. 1. 4 | is the most commonly used indicator -,mainly because it can
97 IV, 11. 1. 5 | evaluation of the Danish indicator project established in 2000
98 IV, 11. 1. 5 | the Health Care Quality Indicator Project to track quality
99 IV, 11. 1. 5 | domains (and a fifth bonus indicator on 'access'). The four domains
100 IV, 11. 1. 5 | additional services. Each indicator is weighed, contributing
101 IV, 11. 6. 5 | indicators: the Danish National Indicator Project." International
102 IV, 11. 6. 5 | Quality evaluation and indicator comparison in health care."
103 IV, 12. 5 | Healthy Life Years” structural indicator, submitted every year to
104 IV, 12. 5 | as European Structural Indicator~ ~Prior to acceptance as
105 IV, 12. 5 | acceptance as EU Structural Indicator, HLY underwent a rigorous
106 IV, 12. 5 | assessment to be a Structural Indicator, HLY was awarded a grade
107 IV, 12. 5 | Especially in the field of indicator development an important
108 IV, 12. 10 | Genomics and public healh~No indicator~ ~ ~Hypertension~No indicator~ ~
109 IV, 12. 10 | indicator~ ~ ~Hypertension~No indicator~ ~Interactions amongst determinants~
110 IV, 12. 10 | amongst determinants~No indicator~ ~ ~ ~ ~B) Actions adopted
111 IV, 13. 2. 3 | been modeled using BMI as indicator. Overweight can also be
